Variable | Univariate Analysis HR (95% CI) | P value | Multivariable Analysis HR (95% CI)a | P value |
---|---|---|---|---|
Gender | ||||
 Female | N/A |  | 1.0 (Reference) |  |
 Male | N/A | N/A | 1.25 (0.95–1.65) | .11 |
Pathologic Stage | ||||
 T0 | N/A |  | 1.0 (Reference) |  |
 T1 | N/A | N/A | 1.29 (0.55–3.00) | .56 |
 T2 | N/A | N/A | 2.41 (1.21–4.80) | .01 |
 T3 | N/A | N/A | 2.60 (1.27–5.29) | .009 |
CCI | ||||
 0–3 | N/A |  | 1.0 (Reference) |  |
 4+ | N/A | N/A | 1.48 (1.05–2.09) | .02 |
NLR | ||||
  < 5 | 1.0 (Reference) |  | 1.0 (Reference) |  |
  ≥ 5 | 1.65 (1.14–2.39) | .008 | 2.20 (1.43–3.39) | .0003 |
PLR | ||||
  < 144.4 | 1.0 (Reference) |  | N/A |  |
  ≥ 144.4 | 0.94 (0.73–1.22) | .64 | N/A | N/A |
LMR | ||||
  < 2.9 | 1.0 (Reference) |  | N/A |  |
  ≥ 2.9 | 0.90 (0.69–1.16) | .41 | N/A | N/A |
Perineural Invasion | ||||
 No | N/A |  | 1.0 (Reference) |  |
 Yes | N/A | N/A | 1.61 (1.08–2.41) | .02 |
Complication Grade (3–4)b | N/A | N/A | 1.64 (1.10–2.44) | .01 |
Positive Nodes | N/A | N/A | 1.08 (1.03–1.12) | .0003 |